Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia: Proposed modification of the task force criteria

Frank I. Marcus, William J. McKenna, Duane Sherrill, Cristina Basso, Barbara Bauce, David A. Bluemke, Hugh Calkins, Domenico Corrado, Moniek G.P.J. Cox, James P. Daubert, Guy Fontaine, Kathleen Gear, Richard Hauer, Andrea Nava, Michael H. Picard, Nikos Protonotarios, Jeffrey E. Saffitz, Danita M. Yoerger Sanborn, Jonathan S. Steinberg, Harikrishna TandriGaetano Thiene, Jeffrey Towbin, Adalena Tsatsopoulou, Thomas Wichter, Wojciech Zareba

Research output: Contribution to journalArticle

1014 Citations (Scopus)

Abstract

In 1994, an International Task Force proposed criteria for the clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated recognition and interpretation of the frequently nonspecific clinical features of ARVC/D. This enabled confirmatory clinical diagnosis in index cases through exclusion of phenocopies and provided a standard on which clinical research and genetic studies could be based. Structural, histological, electrocardiographic, arrhythmic, and familial features of the disease were incorporated into the criteria, subdivided into major and minor categories according to the specificity of their association with ARVC/D. At that time, clinical experience with ARVC/D was dominated by symptomatic index cases and sudden cardiac death victims-the overt or severe end of the disease spectrum. Consequently, the 1994 criteria were highly specific but lacked sensitivity for early and familial disease. METHODS AND RESULTS: Revision of the diagnostic criteria provides guidance on the role of emerging diagnostic modalities and advances in the genetics of ARVC/D. The criteria have been modified to incorporate new knowledge and technology to improve diagnostic sensitivity, but with the important requisite of maintaining diagnostic specificity. The approach of classifying structural, histological, electrocardiographic, arrhythmic, and genetic features of the disease as major and minor criteria has been maintained. In this modification of the Task Force criteria, quantitative criteria are proposed and abnormalities are defined on the basis of comparison with normal subject data. CONCLUSIONS: The present modifications of the Task Force Criteria represent a working framework to improve the diagnosis and management of this condition. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00024505.

Original languageEnglish (US)
Pages (from-to)1533-1541
Number of pages9
JournalCirculation
Volume121
Issue number13
DOIs
StatePublished - Jan 1 2010

Fingerprint

Arrhythmogenic Right Ventricular Dysplasia
Advisory Committees
Genetic Research
Inborn Genetic Diseases
Sudden Cardiac Death
Clinical Trials
Technology

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., ... Zareba, W. (2010). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia: Proposed modification of the task force criteria. Circulation, 121(13), 1533-1541. https://doi.org/10.1161/CIRCULATIONAHA.108.840827

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia : Proposed modification of the task force criteria. / Marcus, Frank I.; McKenna, William J.; Sherrill, Duane; Basso, Cristina; Bauce, Barbara; Bluemke, David A.; Calkins, Hugh; Corrado, Domenico; Cox, Moniek G.P.J.; Daubert, James P.; Fontaine, Guy; Gear, Kathleen; Hauer, Richard; Nava, Andrea; Picard, Michael H.; Protonotarios, Nikos; Saffitz, Jeffrey E.; Yoerger Sanborn, Danita M.; Steinberg, Jonathan S.; Tandri, Harikrishna; Thiene, Gaetano; Towbin, Jeffrey; Tsatsopoulou, Adalena; Wichter, Thomas; Zareba, Wojciech.

In: Circulation, Vol. 121, No. 13, 01.01.2010, p. 1533-1541.

Research output: Contribution to journalArticle

Marcus, FI, McKenna, WJ, Sherrill, D, Basso, C, Bauce, B, Bluemke, DA, Calkins, H, Corrado, D, Cox, MGPJ, Daubert, JP, Fontaine, G, Gear, K, Hauer, R, Nava, A, Picard, MH, Protonotarios, N, Saffitz, JE, Yoerger Sanborn, DM, Steinberg, JS, Tandri, H, Thiene, G, Towbin, J, Tsatsopoulou, A, Wichter, T & Zareba, W 2010, 'Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia: Proposed modification of the task force criteria', Circulation, vol. 121, no. 13, pp. 1533-1541. https://doi.org/10.1161/CIRCULATIONAHA.108.840827
Marcus, Frank I. ; McKenna, William J. ; Sherrill, Duane ; Basso, Cristina ; Bauce, Barbara ; Bluemke, David A. ; Calkins, Hugh ; Corrado, Domenico ; Cox, Moniek G.P.J. ; Daubert, James P. ; Fontaine, Guy ; Gear, Kathleen ; Hauer, Richard ; Nava, Andrea ; Picard, Michael H. ; Protonotarios, Nikos ; Saffitz, Jeffrey E. ; Yoerger Sanborn, Danita M. ; Steinberg, Jonathan S. ; Tandri, Harikrishna ; Thiene, Gaetano ; Towbin, Jeffrey ; Tsatsopoulou, Adalena ; Wichter, Thomas ; Zareba, Wojciech. / Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia : Proposed modification of the task force criteria. In: Circulation. 2010 ; Vol. 121, No. 13. pp. 1533-1541.
@article{d1fe88e22f0f4cdb9eba934474d0ba8b,
title = "Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia: Proposed modification of the task force criteria",
abstract = "In 1994, an International Task Force proposed criteria for the clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated recognition and interpretation of the frequently nonspecific clinical features of ARVC/D. This enabled confirmatory clinical diagnosis in index cases through exclusion of phenocopies and provided a standard on which clinical research and genetic studies could be based. Structural, histological, electrocardiographic, arrhythmic, and familial features of the disease were incorporated into the criteria, subdivided into major and minor categories according to the specificity of their association with ARVC/D. At that time, clinical experience with ARVC/D was dominated by symptomatic index cases and sudden cardiac death victims-the overt or severe end of the disease spectrum. Consequently, the 1994 criteria were highly specific but lacked sensitivity for early and familial disease. METHODS AND RESULTS: Revision of the diagnostic criteria provides guidance on the role of emerging diagnostic modalities and advances in the genetics of ARVC/D. The criteria have been modified to incorporate new knowledge and technology to improve diagnostic sensitivity, but with the important requisite of maintaining diagnostic specificity. The approach of classifying structural, histological, electrocardiographic, arrhythmic, and genetic features of the disease as major and minor criteria has been maintained. In this modification of the Task Force criteria, quantitative criteria are proposed and abnormalities are defined on the basis of comparison with normal subject data. CONCLUSIONS: The present modifications of the Task Force Criteria represent a working framework to improve the diagnosis and management of this condition. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00024505.",
author = "Marcus, {Frank I.} and McKenna, {William J.} and Duane Sherrill and Cristina Basso and Barbara Bauce and Bluemke, {David A.} and Hugh Calkins and Domenico Corrado and Cox, {Moniek G.P.J.} and Daubert, {James P.} and Guy Fontaine and Kathleen Gear and Richard Hauer and Andrea Nava and Picard, {Michael H.} and Nikos Protonotarios and Saffitz, {Jeffrey E.} and {Yoerger Sanborn}, {Danita M.} and Steinberg, {Jonathan S.} and Harikrishna Tandri and Gaetano Thiene and Jeffrey Towbin and Adalena Tsatsopoulou and Thomas Wichter and Wojciech Zareba",
year = "2010",
month = "1",
day = "1",
doi = "10.1161/CIRCULATIONAHA.108.840827",
language = "English (US)",
volume = "121",
pages = "1533--1541",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "13",

}

TY - JOUR

T1 - Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia

T2 - Proposed modification of the task force criteria

AU - Marcus, Frank I.

AU - McKenna, William J.

AU - Sherrill, Duane

AU - Basso, Cristina

AU - Bauce, Barbara

AU - Bluemke, David A.

AU - Calkins, Hugh

AU - Corrado, Domenico

AU - Cox, Moniek G.P.J.

AU - Daubert, James P.

AU - Fontaine, Guy

AU - Gear, Kathleen

AU - Hauer, Richard

AU - Nava, Andrea

AU - Picard, Michael H.

AU - Protonotarios, Nikos

AU - Saffitz, Jeffrey E.

AU - Yoerger Sanborn, Danita M.

AU - Steinberg, Jonathan S.

AU - Tandri, Harikrishna

AU - Thiene, Gaetano

AU - Towbin, Jeffrey

AU - Tsatsopoulou, Adalena

AU - Wichter, Thomas

AU - Zareba, Wojciech

PY - 2010/1/1

Y1 - 2010/1/1

N2 - In 1994, an International Task Force proposed criteria for the clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated recognition and interpretation of the frequently nonspecific clinical features of ARVC/D. This enabled confirmatory clinical diagnosis in index cases through exclusion of phenocopies and provided a standard on which clinical research and genetic studies could be based. Structural, histological, electrocardiographic, arrhythmic, and familial features of the disease were incorporated into the criteria, subdivided into major and minor categories according to the specificity of their association with ARVC/D. At that time, clinical experience with ARVC/D was dominated by symptomatic index cases and sudden cardiac death victims-the overt or severe end of the disease spectrum. Consequently, the 1994 criteria were highly specific but lacked sensitivity for early and familial disease. METHODS AND RESULTS: Revision of the diagnostic criteria provides guidance on the role of emerging diagnostic modalities and advances in the genetics of ARVC/D. The criteria have been modified to incorporate new knowledge and technology to improve diagnostic sensitivity, but with the important requisite of maintaining diagnostic specificity. The approach of classifying structural, histological, electrocardiographic, arrhythmic, and genetic features of the disease as major and minor criteria has been maintained. In this modification of the Task Force criteria, quantitative criteria are proposed and abnormalities are defined on the basis of comparison with normal subject data. CONCLUSIONS: The present modifications of the Task Force Criteria represent a working framework to improve the diagnosis and management of this condition. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00024505.

AB - In 1994, an International Task Force proposed criteria for the clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated recognition and interpretation of the frequently nonspecific clinical features of ARVC/D. This enabled confirmatory clinical diagnosis in index cases through exclusion of phenocopies and provided a standard on which clinical research and genetic studies could be based. Structural, histological, electrocardiographic, arrhythmic, and familial features of the disease were incorporated into the criteria, subdivided into major and minor categories according to the specificity of their association with ARVC/D. At that time, clinical experience with ARVC/D was dominated by symptomatic index cases and sudden cardiac death victims-the overt or severe end of the disease spectrum. Consequently, the 1994 criteria were highly specific but lacked sensitivity for early and familial disease. METHODS AND RESULTS: Revision of the diagnostic criteria provides guidance on the role of emerging diagnostic modalities and advances in the genetics of ARVC/D. The criteria have been modified to incorporate new knowledge and technology to improve diagnostic sensitivity, but with the important requisite of maintaining diagnostic specificity. The approach of classifying structural, histological, electrocardiographic, arrhythmic, and genetic features of the disease as major and minor criteria has been maintained. In this modification of the Task Force criteria, quantitative criteria are proposed and abnormalities are defined on the basis of comparison with normal subject data. CONCLUSIONS: The present modifications of the Task Force Criteria represent a working framework to improve the diagnosis and management of this condition. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00024505.

UR - http://www.scopus.com/inward/record.url?scp=75249096712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75249096712&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.108.840827

DO - 10.1161/CIRCULATIONAHA.108.840827

M3 - Article

C2 - 20172911

AN - SCOPUS:75249096712

VL - 121

SP - 1533

EP - 1541

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 13

ER -